Bovine helper T cell clones recognize five distinct epitopes on Babesia bovis merozoite antigens. by W C Brown et al.
INFECrION AND IMMUNITY, OCt. 1992, p. 4364-4372 Vol. 60, No. 10
0019-9567/92/104364-09$02.00/0
Copyright © 1992, American Society for MicrobiologY
Bovine Helper T Cell Clones Recognize Five Distinct
Epitopes on Babesia bovis Merozoite Antigens
WENDY C. BROWN,1* SHUMIN ZHAO,1 ALLISON C. RICE-FICHT,2
KATHLEEN S. LOGAN,1 AND VIVIENNE M. WOODS1
Department of Veterinary Pathobiology1 and Department ofMedical Biochemistry and Genetics, 2
Texas A&M University, College Station, Texas 77843
Received 9 June 1992/Accepted 3 August 1992
Helper T cell clones from two Babesia bovis-immune cattle were characterized for use in identification of
potentially protective immunogens of B. bovis merozoites. Proliferation assays with 11 CD4+ clones revealed
a differential pattern of response to soluble cytosolic antigen, membrane-enriched antigen, detergent extracts
of the membrane-enriched antigen, soluble culture supernatant exoantigen, and different geographical isolates
of B. bovis as well as Babesia bigemina parasites. When the data were combined, the clones could be grouped
according to five different patterns of response. One group recognized only the membrane-enriched fraction of
New World and Australian parasites. Four remaining groups recognized antigens found in the cytosolic as well
as the membrane-enriched fraction, and clones representative of each group were used to identify cytosolic
antigens fractionated by anion-exchange chromatography with the use of fast-performance liquid chromatog-
raphy. One clone (C97.3C3), which responded to all B. bovis isolates and to B. bigemina, recognized a single
peak of activity that eluted with 0.25 M NaCI and contained protein bands of 70 and 75 kDa. The remaining
clones were stimulated by a second antigenic peak that eluted between 0.35 and 0.45 M NaCl and contained
protein bands of 42, 47, 56, and 84 kDa. The majority of the clones produced interferon, whereas tumor
necrosis factor alpha/tumor necrosis factor beta production was less frequent. These studies provide the basis
for using helper T cell clones to identify potentially protective immunogens ofB. bovis and delineate a minimum
of five helper T cell epitopes recognized by two immune cattle.
The tick-borne intraerythrocytic protozoan parasite Babe-
sia bovis causes a virulent form of babesiosis, characterized
by anemia, fever, anorexia, cachexia, low parasitemia, and a
generalized circulatory disturbance, often resulting in high
mortality rates among nonimmune cattle. One hallmark of
this disease is the sequestration of parasitized erythrocytes
in the capillary beds of the brain and lung, leading to cerebral
babesiosis and respiratory distress syndrome (48-50). Simi-
larity in the immunopathology caused by this parasite and
related apicomplexan parasites in the genus Plasmodium has
led to the hypothesis that the diseases caused by these
hemoparasites share common mechanisms (49, 50). Cyto-
kines, including gamma interferon (IFN--y) and tumor necro-
sis factor (TNF) (7), released by parasite antigen-activated T
cells and macrophages are implicated in anemia (16, 28),
cytoadherence of parasitized erythrocytes to the brain mi-
crocapillary endothelia (20, 21), and accumulation of in-
fected erythrocytes and neutrophils in the pulmonary vascu-
lature (17).
Protective immunity in experimental murine malaria and
babesial infections is mediated by T cells and macrophages
(1, 8, 14, 15, 26, 36, 47), and the same cytokines involved in
immunopathology play a role in protective immunity (17,
37-39, 41). For example, IFN--y inhibited the intrahepato-
cytic development ofPlasmodium berghei parasites (37) and
was required for protective immunity to sporozoite chal-
lenge (38). Heat-stable, soluble exoantigens of Plasmodium
falciparum and Plasmodium yoelii have been shown to
induce the production of TNF from activated macrophages
in vitro and in vivo (4-6, 33, 40), and in vivo administration
of recombinant TNF inhibited parasitemias caused by infec-
* Corresponding author.
tion with P. yoelii (41) and Plasmodium chabaudi (39).
Although definitive studies on the role of cytokines in
babesiosis have not been performed with B. bovis, supema-
tants from macrophages incubated with culture-derived
babesial exoantigens were shown to inhibit parasite growth
in vitro (29). Furthermore, the hypothesis that T cell-mac-
rophage interactions are involved in both immunity and
pathogenesis is supported by the observations that para-
sitemias were higher and cerebral sequestration occurred
less frequently in splenectomized cattle infected with B.
bovis (48).
Identification of parasite antigens which evoke immunity
and/or immunopathology during the course of hemoparasitic
infection is essential for vaccine development. In studies
with B. bovis, attempts to characterize protective antigens
have historically relied upon the use of antibodies to identify
immunodominant proteins. Although antibody may play a
role in merozoite neutralization (25), it has become increas-
ingly evident that serologically immunodominant antigens
are not always protective against a challenge B. bovis
infection (19, 44, 46, 49); and in some studies protective
immunity to B. bovis was inversely related to antibody titer
(49). These observations, together with the documented
relevance of T cells and macrophages in both immunity and
immunopathology associated with infection by related he-
moparasites, have prompted a detailed investigation of cell-
mediated immune responses in B. bovis-infected cattle.
Because B. bovis has no known exoerythrocytic stage which
could serve as a target for major histocompatibility complex
(MHC)-restricted cytotoxic T cells, our research has focused
on the identification of babesial merozoite antigens which
induce T helper (Th) cell responses in immune cattle and on
characterization of the cytokines produced by Babesia-
specific Th cells. We recently described the preferential
4364
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
B. BOVWS-SPECIFIC Th CELLS DEFINE FIVE EPITOPES 4365
stimulation of CD4+ T cells by unfractionated cytosolic and
membrane merozoite antigens of B. bovis (10). The differen-
tial pattern of response by T cell lines derived from three
immune cattle suggested the presence of multiple immuno-
dominant epitopes. In the studies reported here, we have
further dissected these responses by examining a panel of Th
clones derived from several Babesia-specific T cell lines. At
least five distinct Th epitopes can be defined by the patterns
of response to different parasite isolates and antigenic frac-
tions. Preliminary studies on the production of IFN--y and
TNF-a or TNF-1 demonstrate a functional heterogeneity
among the Th clones. Together, these experiments provide
the foundation for using Th clones to identify potentially
protective antigens which may be useful in the development
of a vaccine for B. bovis.
MATERIALS AND METHODS
Babesial parasite strains and cultivation. The Mexican
strain of B. bovis was originally isolated in 1978 from cattle
infected with natural, tick-derived isolates from an area of
Mexico in which babesiosis is endemic (11). The Texan
strain of B. bovis originated from an infected animal in
southern Texas in 1978 (32) and was provided by Will Goff
(USDA Agricultural Research Service, Pullman, Wash.).
The Australian L strain of B. bovis originated from an
infected animal in New South Wales, Australia, in 1965 (27)
and was provided by Stephen Hines (Washington State
University, Pullman). The Mexican strain of Babesia bige-
mina was obtained from an infected animal in northeastern
Mexico in 1982 (11). In vitro microaerophilous cultures of all
babesial strains were maintained in bovine erythrocytes (11).
Experimental cattle. Cattle were infected with the Mexican
strain of B. bovis as described in detail elsewhere (11).
Briefly, 2-year-old crossbred cow C15 was inoculated intra-
venously three times over the course of 3 years with B. bovis
merozoites obtained from autologous, infected erythrocyte
cultures. Although animal C15 has not been challenged with
tick- or blood-derived parasites, challenge inoculation of 109
cultured parasites did not evoke a reduction in packed
erythrocyte volume or elevation in temperature. Animal
C97, a 9-month-old crossbred cow, was infected by infesta-
tion with Boophilus microplus tick larvae infected with the
same isolate of B. bovis. The animal was solidly immune to
challenge infection 3 months later with an intramuscular
inoculation of a virulent, infected tick stabilate. A Babesia-
naive animal used as a control to assess the virulence of the
parasite stabilate became clinically ill, experiencing a 57%
reduction in packed erythrocyte volume on day 14 post-
challenge. Following infection, both animals were serologi-
cally positive for B. bovis as determined by indirect immu-
nofluorescence staining of cultured parasites and by
immunoblotting merozoite antigen (11). Peripheral blood
mononuclear cells (PBMC) from cattle C15 and C97 were
typed for bovine class I MHC antigens (42) and had the
bovine lymphocyte antigen (BoLA) phenotypes wll/w12
and w51w6, respectively.
Parasite antigens. Crude parasite antigens were prepared
by homogenization of culture-derived merozoites with a
French pressure cell (SLM Instruments, Inc., Urbana, Ill.)
and ultracentrifugation to yield a soluble, cytosolic, high-
speed supernatant fraction (HSS) and a fraction enriched in
crude membranes (CM) as described previously (11). Unin-
fected erythrocytes (URBC) were similarly fractionated for
use as control antigens. Detergent solubilization of the CM
fraction was achieved with 1% 3-[(3-cholamidopropyl)-di-
methyl-ammonio]-1-propanesulfonate (CHAPS) (Pierce,
Rockford, Ill.) (10), and the extracts were then dialyzed
against phosphate-buffered saline, pH 7.0, at 4°C.
Soluble merozoite HSS was fractionated by anion ex-
change on a Mono Q (HR 5/5) column using a fast-perfor-
mance liquid chromatography (FPLC) apparatus (Pharmacia
LKB Biotechnology, Piscataway, N.J.). HSS was dialyzed
against the starting buffer (20 mM N-2-hydroxyethylpipera-
zine-N'-2-ethanesulfonic acid [HEPES]) and filtered, and 7
ml containing 1 mg of protein per ml was loaded onto the
Mono Q column. The bound proteins were eluted with a
20-ml linear NaCl gradient of 0.0 to 1.0 M NaCl in 20 mM
HEPES at a flow rate of 1.0 mlmin, and protein was
monitored at 280 nm. Individual 1.0-ml fractions were col-
lected and diluted to isotonicity (150 mM NaCl) for T cell
proliferation studies. Supernatants containing parasite exo-
antigens were collected from cultures of B. bovis (Mexico)-
infected erythrocytes or URBC and were also assessed for
antigenic activity.
The recombinant 42-kDa B. bovis protein Bv42 (25) was
obtained from Guy Palmer (Washington State University,
Pullman). The recombinant 77-kDa fusion protein Bb-1-GST
was described previously (43). Tuberculin purified protein
derivative (Statens Seruminstitut, Copenhagen, Denmark)
was used as a negative control.
The protein content in all antigen preparations was deter-
mined by the Bio-Rad protein assay (Bio-Rad Laboratories,
Richmond, Calif.) using immunoglobulin G (IgG) as a protein
standard. All antigens were aliquoted and stored at -80°C.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) analysis of FPLC fractions. FPLC fractions
(17.5 ,ul) were diluted with an equal volume of sample buffer,
electrophoresed on 10 or 12% acrylamide gels under reduc-
ing conditions, and stained with a silver staining kit from
Bio-Rad (10).
Generation of B. bovis-specific T cell clones. T cell lines
established from PBMC from immune cattle C15 and C97
and specific for B. bovis merozoites were described in a
previous publication (10). Briefly, a cell line from animal C97
was stimulated with B. bovis (Mexico) CM for 5 weeks, and
a cell line from animal C15 was stimulated for 4 weeks with
the same stock of CM and for an additional 2 weeks with
HSS prepared from these parasites. An additional cell line
from animal C15 was stimulated for 1 week with CM and 2
weeks with HSS prepared from the Mexican isolate of B.
bovis. All three cell lines were shown to proliferate in a
dose-dependent manner to B. bovis (Mexico) merozoite
antigens and were selected for limited dilution cloning.
Cloning was performed in 96-well round-bottomed plates
(Costar, Cambridge, Mass.) essentially as described else-
where (12, 43), with the following modifications. A statistical
average of 1 or 0.3 cell per well was stimulated with 25 ,ug of
B. bovis (Mexico) CM (for the C97 T cell line) or HSS (for
the C15 T cell lines) antigen per ml of complete RPMI 1640
medium (11) containing 10% bovine T cell growth factor
(TCGF [9]) and 5 x 104 irradiated autologous PBMC. Six or
seven days after the last stimulation, cells were tested for
antigen-dependenf proliferation.
Cell surface phenotypic analysis. Antigen-specific clones
were stained by indirect immunofluorescence as described
previously (43) and analyzed by flow cytometry with a
Coulter EPICS 741 flow cytometer. Monoclonal antibodies
(MAb) specific for bovine leukocyte surface markers were
obtained from the International Laboratory for Research on
Animal Diseases (Nairobi, Kenya): IL-A51, specific for CD8
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(18); IL-A12, specific for CD4 (3); and IL-A26, specific for
CD2 (2).
Lymphocyte proliferation assays. Proliferation assays were
carried out in duplicate wells of half-area 96-well plates
(Costar) at 37°C, in a humidified atmosphere of5% CO2 in air
for 3 days as described elsewhere (12, 43). Each well (100-pl
total volume) contained complete medium, responder cells
added at a final concentration of 2 x 105 or 3 x 105 cells per
ml (obtained 6 or 7 days following the last stimulation of the
cell lines with antigen), and 2 x 106 autologous or allogeneic,
irradiated (3,000 rads) PBMC per ml as a source of antigen-
presenting cells (APC). Antigens were added to the assay
mixes at a final concentration of 1 to 250 ,ug of protein per ml
of complete medium. Bovine TCGF (5%) or recombinant
human interleukin 2 (IL-2; Boehringer Mannheim, Indianap-
olis, Ind.) (5 or 25 U/ml) was included as a positive control
for lymphocyte proliferation. Unless indicated otherwise,
clone C15.1H6 was cultured in the presence of 2% TCGF, in
addition to antigen, in all wells of the proliferation assays. In
some experiments, a MAb, designated IL-A21 (International
Laboratory for Research on Animal Diseases), specific for a
monomorphic determinant on bovine MHC class II, was
included to block antigen presentation. The IgG was purified
from ascitic fluid (kindly provided by John Ellis, University
of Wyoming, Laramie) by binding to protein G (MabTrap G;
Pharmacia) according to the manufacturer's directions. Pu-
rified IgG was then added to T cells, APC, and antigen or
TCGF at a final concentration of 25 ,ug of IgG per ml. In
some experiments an isotype-matched control MAb was
included. Proliferation was determined by measuring the
incorporation of 0.25 ,uCi of [1"IJiododeoxyuridine ('"IUdR;
ICN Radiochemicals, Inc., Costa Mesa, Calif.) added during
the final 4 h of the assay. The cells were harvested (11), and the
radioactivity was counted in a gamma counter. Results are
presented as the mean counts per minute and standard devi-
ations of duplicate samples. When mismatched APC were
included in the assays, results are also presented as the
percentage of the proliferative response of the T cell clone
stimulated with antigen or TCGF with autologous APC.
The one-tailed Student t test was used to determine the
levels of significance between control and experimental
cultures.
Stimulation of T cell clones for cytokine production. T cells
obtained 6 or 7 days after the last stimulation with antigen
plus APC were washed in complete medium and cultured for
17 to 24 h at a concentration of 2 x 106 cells per ml of
complete medium containing 5 ,ug of concanavalin A (Sigma
Chemical Co., St. Louis, Mo.) per ml in the absence of APC.
Supernatants were harvested by centrifugation and stored at
-800C.
Biological assays for IFN and TNF. IFN activity in super-
natants was measured in a microtiter cytopathic effect assay
with vesicular stomatitis virus and Madin-Darby bovine
kidney (MDBK) cells as described elsewhere (12). MDBK
cell survival was evaluated by the 4-h uptake of MTT dye in
the cells (22). IFN titers were compared with a human
recombinant IFN-a2 reference reagent (National Institute of
Allergy and Infectious Diseases, Bethesda, Md.; catalog no.
GxaOl-901-535) with a reported activity of 9,000 or 3.95 log1o
IU/ml. In our assay, this standard had a titer of 3.35 + 0.18
log1o IU/ml.
For determination of TNF-alTNF-13 activities in superna-
tants of B. bovis-specific T cell clones, a TNF-sensitive
WEHI-164 subline originating from Edward Lattime (Memo-
rial Sloan-Kettering, New York, N.Y.) was incubated with
culture supernatants in a 48-h assay (35). Cytopathicity was
determined by the MTT dye reduction assay. TNF titers in
the supernatants were compared with the standard human
recombinant TNF-at (Upstate Biotechnology Inc., Lake
Placid, N.Y.), which had a reported activity of 106 U/ml and
in our assay had a titer of 5.92 + 0.15 log1o U/ml.
RESULTS
B. bovis-specific T cell clones. Three B. bovis-specific T cell
lines were stimulated with either the CM or HSS of mero-
zoites and were cloned by limiting dilution. Cloning frequen-
cies of 16.6 and 25.5%, respectively, were obtained from the
C97 and C15 T cell lines when an average of 0.3 T cell was
distributed per well. The majority of clones were B. bovis
specific, totaling 29 C97 clones and 34 C15 clones. For the
second C15 T cell line, cultured for 3 weeks and cloned with
an average of 1 T cell per well, a cloning frequency of 58%
was obtained. Nine clones responded to antigen, and one,
designated C15.1H6, was subcloned. All six subclones re-
sponded to antigen (data not presented), so the more vigor-
ous parent clone was used in subsequent assays. All of the
clones expressed the surface phenotype characteristic of Th
cells: CD2+ CD4+ CD8-. The 11 clones described in this
study were initially selected on the basis of proliferation to
babesial antigen in the absence of exogenous IL-2.
Differential response of Th clones to HSS and CM of
homogenized merozoites. Several different patterns of re-
sponse to crude B. bovis antigens were observed, as exem-
plified by results with four clones shown in Fig. 1. The
majority of the clones derived from the C97 cell line re-
sponded to the CM but not to the soluble HSS of merozoites
(Fig. 1A). However, two clones, C97.3E9 and C97.3E12,
responded strongly to both CM and HSS (Fig. 1B), and a
third clone, C97.3C3, proliferated weakly in response to
HSS as compared with CM (Fig. 1C). All C15 clones
responded vigorously to both CM and HSS (Fig. 1D). None
of the clones responded to HSS or CM prepared from URBC
(data not presented and Tables 1 and 3).
Differential response of Th clones to detergent extracts of
merozoite CM. Detergent extraction of merozoite membrane
proteins was performed to evaluate the potential to use Th
clones to probe for detergent-solubilized proteins during
purification procedures. The Th clones exhibited the same
pattern of response to CHAPS extracts ofB. bovis CM as did
the parent cell lines (10). With the exception of clone
C15.1H6, all C15 clones responded vigorously to CHAPS
extract, whereas the C97 clones, including HSS-responsive
clone C97.3E9, responded weakly or not at all to this
preparation of antigen (Table 1).
Differential response of Th clones to culture supernatant
exoantigens. We had previously determined that the parasite-
specific cell lines from animal C15, but not C97, were
stimulated by antigens in the parasite culture supernatant
(10). Th clones derived from these lines reacted in a similar
manner, in that the C97 clones responded poorly or not at all
to the soluble exoantigen whereas four of six C15 clones
were stimulated by the parasite culture supernatant (data
from representative clones are presented in Table 2).
Differential response of Th clones to B. bovis and B.
bigemina isolates. It was of interest to determine whether the
Th clones recognized antigens shared between different
geographical isolates of B. bovis, since inclusion of common
antigens in a vaccine would be preferential. Selected clones
were cultured with the CM of Mexican (immunizing isolate),
Texan, or Australian B. bovis merozoites all propagated in
vitro in erythrocytes from the same uninfected donor animal
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FIG. 1. Dose-dependent proliferation of Th clones against cytosolic and membrane-enriched fractions of B. bovis merozoites. Repre-
sentative proliferative responses of 4 clones, out of a total of over 60, to B. bovis (Mexico) HSS (closed circles) or CM (open circles) antigens
are presented.
(results with representative clones are shown in Table 3). A
differential pattern of response emerged: five of seven C97
clones responded to all B. bovis isolates, whereas two clones
responded only to the Mexican and Texan isolates. Only one
of four C15 Th clones responded to all three B. bovis
isolates, and the remaining three clones responded to both
Mexican and Texan isolates. Previous studies indicated a
differential response of T cells from animals C97 and C15 to
B. bigemina parasites, in that C15 cells responded as well to
B. bigemina as to B. bovis whereas the C97 cells were
stimulated weakly or not at all by this parasite (10, 11).
However, when the Th clones were examined for prolifera-
tion to B. bigemina, only one clone (C97.303) responded to
this parasite, and its proliferation against B. bigemina was
consistently higher than that against B. bovis (Table 3).
Proliferative responses ofTh clones to recombinant babesial
proteins. None of the Th clones recognized either a recom-
binant form of the 42-kDa major merozoite surface glyco-
protein, Bv42 (25), or the recombinant 77-kDa merozoite
fusion protein, Bb-1-GST (43, 45) (data not presented), both
ofwhich have been shown to induce proliferation of CD4+ T
cells in these two animals (13, 43). As expected, none of the
Th clones responded to purified protein derivative of Myco-
bacterium bovis (data not presented).
Th clones are MHC class H restricted. To ensure that the
Th clones recognized parasite antigen in an MHC-restricted
TABLE 1. Proliferative responses of B. bovis-specific Th cell clones to detergent-solubilized merozoite membranes
Radioactivity (mean cpm ± SD) incorporated by T cell lines stimulated witha:
Clone Medium
(control) URBC CM B. bovis CM CHAPS extract
C97.2E4 235 ± 14 286 ± 9 51,918 ± 507 10,246 ± 43
C97.3C3 2,432 ± 77 2,492 ± 572 23,604 ± 184 896 ± 89
C97.3E9 625 ± 25 652 ± 12 25,314 ± 707 1,649 ± 158
C15.1H6 436 ± 15 596 ± 11 11,370 ± 764 728 ± 120
C15.2D7 587 ± 3 662 ± 2 44,720 - 934 33,612 ± 1,779
a Antigens, prepared from URBC or the Mexican isolate of B. bovis, were used at a final protein concentration of 5 pg/ml except that 10 ag of CHAPS per ml
was used to stimulate the C97 T cell clones.
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TABLE 2. Proliferative responses of B. bovis-specific Th cell
clones to culture supernatant exoantigen
Radioactivity (mean cpm + SD) incorporated by
T cell clones stimulated with supernatants"
Clone collected from:
URBC B. bovis (Mexico)-infected erythrocytes
C97.2E4 362 ± 107 1,671 ± 396
C97.3C3 490 ± 10 1,137 ± 58
C97.3E9 826 ± 54 790 ± 22
C15.1H6 678 ± 61 731 ± 19
C15.2D7 697 ± 32 12,961 ± 1,111
I A final protein concentration of 200 or 250 jg/ml was used in the assay.
manner and were not being stimulated by parasite-derived
superantigens (23), selected clones were compared for stim-
ulation with antigen or TCGF as a control, in the presence of
either autologous or MHC-mismatched APC which were
known to differ in expression of BoLA class I antigens
(Table 4). When mismatched APC were used to present B.
bovis antigen, the proliferative responses of all Th clones
were completely abrogated. TCGF-induced proliferation
was either not affected or only partially inhibited in the
presence of mismatched APC. Inclusion of purified IgG from
a MAb (IL-A21) specific for bovine MHC class II resulted in
86 to 99% inhibition of antigen-induced proliferation of all
clones tested at a concentration of 25 p,g of IgG per ml (data
not presented), showing that the Th clones respond to
babesial antigen in an MHC class II-restricted manner.
Nonspecific toxicity of the IgG was ruled out by the absence
of inhibition of the response of the clones to TCGF. An
additional control using an isotype-matched (IgG2a) MAb
was included in the experiment, and although this antibody
nonspecifically inhibited the proliferation to TCGF at a
concentration of 25 ,ug/ml or higher (65% inhibition versus
0% inhibition by MAb IL-A21 of the response of clone
C97.3C3), the antigen-specific response was not inhibited by
the control MAb to the same extent as by MAb IL-A21 (48%
inhibition versus 99% inhibition by MAb IL-A21 of the
response of clone C97.3C3).
Fractionation of B. bovis HSS antigen by FPLC anion-
exchange chromatography. Because many of the B. bovis-
specific Th clones could be stimulated by soluble antigen
present in the HSS of merozoites, several clones were used
TABLE 4. Proliferative responses of B. bovis-specific Th cell
clones with autologous or MHC-mismatched APC
Radioactivity (mean cpm ± SD) incorporated
TCGF by T cells stimulated with:
Clone or
antigen uoogu P MHC-mismatchedantigenaAutologous APC APCb (%oC)
C97.2E4 TCGF 5,476 ± 418 6,645 ± 601 (121)
CM 45,023 ± 4,720 394 ± 29 (<1)
C97.3C3d CM 18,864 ± 819 164 ± 4 (<1)
C97.3E9 TCGF 38,972 ± 2,336 47,978 ± 1,126 (123)
CM 37,400 ± 1,509 727 ± 1 (<1)
C15.1H6 TCGF 5,970 ± 723 5,570 ± 283 (93)
HSS 16,041 ± 581 450 ± 27 (<1)
C15.2D7 TCGF 22,669 ± 1,009 7,603 ± 224 (33)
HSS 62,693 ± 1,275 368 ± 7 (<1)
a TCGF was used in the assay at a final concentration of 5%, with the
exception of clone C15.1H6, for which it was used at a final concentration of
12%. B. bovis (Mexico) antigen (CM or HSS) was used in the assay at a final
concentration of 25 pg of protein per ml.
b Irradiated C15 PBMC were used as mismatched APC for C97 Th clones,
and irradiated C97 PBMC were used as mismatched APC for C1S Th clones.C Percentage of the response of Th clone with autologous APC.
d Results with TCGF were not determined.
in an attempt to identify antigenic proteins present in HSS
fractionated by anion-exchange chromatography using
FPLC. Figure 2A shows that the antigenic activity for clone
C97.3C3 eluted in a single peak with 0.25 M NaCl, whereas
clones C97.3E9, C15.1H6, C15.2D7, and C15.3A5 were all
stimulated by antigen eluting between 0.35 and 0.45 M NaCl
(Fig. 2B and C). As a negative control, a Th clone (C97.1C8)
reactive with recombinant Bb-l-GST, which did not respond
to HSS (43), was similarly tested and did not respond to any
of the fractions (data not presented).
Examination of the individual FPLC fractions by SDS-
PAGE and silver staining (Fig. 3) revealed the presence of
two bands of 70 and 75 kDa, apparently unique to the peak
of activity eluting with 0.25 M NaCl (lane B), which stimu-
lated only clone C97.3C3. The peak of antigenic activity in
fractions eluting with 0.35 to 0.45 M NaCl (Fig. 3, lane D)
contained numerous proteins, including prominent ones of
42, 47, 56, and 84 kDa.
Cytokine production by the Th clones. Biological assays for
TNF-afINF-1 and IFN--y were used to detect the produc-
tion of these cytokines following stimulation of the Th clones
TABLE 3. Proliferative responses of B. bovis-specific Th cell clones to B. bigemina and different isolates of B. bovis
Mean cpm of 1OIUdR incorporation (SD) with":
Antigen B. bovis from:
Clone concn
64&gmi) Medium URBC Australia B. bigeminaMexico Texas (L strain)
C97.3C3 25 489 (138) 429 (10) 12,025 (2,129) 5,543 (741) 18,145 (2,224) 30,063 (1,172)
C97.2E4 25 734 (54) 743 (11) 43,569 (148) 38,798 (1,928) 48,052 (1,485) 731 (10)
C15.1H6b 25 11,642 (622) 12,213 (26) 53,087 (104) 48,291 (60) 45,722 (1,016) 10,163 (634)
C97.3E9 25 1,042 (37) 1,152 (26) 21,462 (292) 7,542 (1,250) 1,342 (44) 1,014 (114)
C15.2D7c 25 570 (117) 416 (9) 31,270 (1,640) 28,614 (1,911) 455 (37) ND
5 587 (3) 662 (2) 44,720 (934) ND ND 622 (21)
aResults of duplicate cultures. Results indicated in boldface type were shown to be significantly different from those with control cultures (P < 0.01) by the
Student one-tailed t test. Antigen consisted of the CM of URBC, B. bovis merozoites, or B. bigemina originating from Mexico. Results are presented for
stimulation with 25 F&g of antigen per ml, except for clone C15.2D7, for which the B. bigemina antigen was tested at 5 jg of protein per ml. Controls are included
for this experiment. ND, not determined.
b Clone C15.1H6 was assayed in the presence of 5 U of human IL-2 per ml.
I Data from two experiments are presented for clone C15.2D7 to include all relevant results.
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FIG. 2. Proliferative responses of five Th clones to B. bovis
(Mexico) HSS antigen fractionated by anion-exchange chromatog-
raphy using FPLC. HSS was applied onto the Mono Q column,
eluted with a linear NaCl gradient (-), and monitored for protein
at 280 nm (---) on a scale of 0 (baseline) to 1.0 (maximum peaks)
U of absorbance. FPLC fractions were diluted to isotonicity, and
25-pl samples were assayed in duplicate cultures with the following
Th clones and autologous APC: C97.3C3, C97.3E9 (plus 5 U of IL-2
per ml) and C15.1H6 (plus 2.5% TCGF), and C15.2D7 and C15.3A5.
The symbols indicate the proliferative responses of the indicated
clones to individual fractions.
with concanavalin A (Table 5). The majority of Th clones
produced IFN-y, with activity ranging from barely detect-
able (2 U/ml) to 226 U/ml. TNF-afI`NF-1 production by
these clones was also variable, ranging from undetectable to
13 U/ml. Interestingly, three clones produced no detectable
cytokines (clones C15.2D7 and C15.3A5 are represented)
z
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z
0
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_m _ _
FIG. 3. SDS-PAGE and silver staining of selected FPLC frac-
tions. Fractions eluting with the following concentrations of NaCl
are shown: lane A, 0.15 M; lane B, 0.25 M; lane C, 0.35 M; lane D,
0.40 M; lane E, 0.45 M; and lane F, 0.50 M. Molecular size markers
are indicated on the left, and individual bands of 84, 75, 70, 56, 47,
and 42 kDa are indicated with arrowheads.
following our stimulation protocol. All of the Th clones
responded to stimulation with IL-2, and those with undetect-
able IFN--y and TNF-ax/TNF-13 activities had the highest
proliferative responses to IL-2.
DISCUSSION
T lymphocytes are known to be important for the devel-
opment of protective immunity against many intracellular
protozoan parasites. However, the nature of protective
immunity, including the subsets of T cells induced, in
response to the cattle parasite B. bovis have not been
characterized. We have identified a panel ofBabesia-specific
CD4+ T cell clones for use in identification of T cell
immunodominant antigens that could be purified from solu-
ble merozoite extracts and for functional characterization of
TABLE 5. Proliferative responses to IL-2 and production of
cytokines by B. bovis-specific Th cell clones
Cytokine
Clone Specificity Stimulation produced (U/ml)'
IFN TNF
C97.2E4 CM 9 18 <2
C97.3C3 CM, HSS 11 200 13
C97.3E9 CM, HSS 3 226 3
C15.1H6 CM, HSS 18 41 6
C15.2D7 CM, HSS 41 <2 <2
C15.3A5 CM, HSS 93 <2 <2
a Calculated as 100 x mean cpm of 125IUdR incorporation of du4licate
cultures of a Th cell clone in response to IL-2/mean cpm of 1 IUdR
incorporation of duplicate cultures of Th cells with medium alone. Human
recombinant IL.2 was added at a final concentration of 25 U/ml, except for
clones C97.2E4 and C97.3E9, which were stimulated with 5 U of IL-2 per ml.
b Cytokine activity was measured in the supernatants of Th cell clones
cultured for 17 to 24 h with 5 Ag of concanavalin A per ml.
z
U
cc
0.
I,
08
co
z
I
8
'U
0
VI
00
0
U
0
VOL. 60, 1992
- .1
qkmmmm- iL.-ii'44 1 -49
s- 0
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
4370 BROWN ET AL.
TABLE 6. Summary of B. bovis-specific Th cell clones that define at least five antigenic epitopes in crude merozoite homogenate
Responsea to:
Group and Unfractionated B. bovis antigenb Parasite isolates
clones B oi rm
HSS CM CHAPS EXO B. bovas from: B. bigemina from
Mexico Texas Australia Mexico
C97.2A6 - + ++ + +
C97.2D2 - + + + + + + -
C97.2E4 - + + + + + + -
C97.3E8 - + + - + + + -
II
C97.3C3 + + - + + + + +
III
C15.lH6 + + - - + + + -
IV
C97.3E9 + + + + + - -
C97.3E12 + + + _ + + - -
V
C15.2B1 + + + + + + - -
C15.2D7 + + + + + + - -
C15.3A5 + + + + + + - -
a Proliferative responses of the individual Th clones in each of the five groups are indicated as follows: +, positive response; +, weakly positive response; and
-, negative response.
b B. bovis HSS, CM, CHAPS extract of the CM, and soluble culture supernatant (EXO) antigens were prepared from merozoites of the Mexican isolate.
the T cells. The results presented here are the first to
describe a differential pattern of response of MHC class
II-restricted, CD4+ bovine T cell clones stimulated with
soluble or membrane-enriched B. bovis merozoite antigens.
On the basis of the patterns of proliferative responses
against unfractionated merozoite antigens and different geo-
graphical isolates of B. bovis and B. bigemina, 11 Th clones
fall into groups which appear to recognize at least five
different antigenic epitopes, as summarized in Table 6. The
first group of Th clones, all derived from animal C97 (clones
2A6, 2D2, 2E4, and 3E8), responded to the CM of parasites.
There was no proliferation to soluble HSS and only little or
no response to either CHAPS extract of CM or culture
supernatant exoantigen. The epitope(s) recognized by these
clones is present in New World and Australian isolates of B.
bovis, but not B. bigemina, parasites.
The remaining Th clones recognized antigens present in
both CM and HSS of merozoites and fall into an additional
four groups. The second group is represented by clone
C97.3C3, which recognizes an antigenic epitope shared by
all B. bovis and B. bigemina parasites that is not extractable
from the CM with CHAPS. The third group is represented by
clone C15.1H6, which recognizes an antigen in HSS and CM
shared by all B. bovis isolates which is not found in B.
bigemina. The fourth group is represented by clones
C97.3E9 and C97.3E12, which, unlike clone C15.1H6, rec-
ognize an antigen found only in New World isolates of B.
bovis. Finally, the majority of C15 clones belong to a fifth
group which recognize an antigen(s) found only in New
World isolates of B. bovis and present in HSS, CM, CHAPS
extract of the CM, and parasite culture supernatants. Thus,
at least five distinct epitopes of B. bovis merozoite antigens
can be distinguished by the induction of differential Th cell
responses.
Four of these different epitopes are present in the cyto-
solic HSS, and fractionation of this soluble form of antigen
by FPLC anion-exchange chromatography has indicated that
activity elutes in two major peaks. Clone C97.3C3 is stimu-
lated by fractions eluting with 0.25 M NaCl which contain
proteins of 70 and 75 kDa apparently not present in neigh-
boring fractions. The relative molecular masses of two of
these proteins are consistent with stress-induced proteins
belonging to the hsp 70 group (34). In this respect, it is
intriguing that clone C97.3C3 recognizes a determinant
shared across divergent babesial species, as parasite stress
proteins are often highly conserved across species as well as
genera (31). The Bb-1 gene, which is conserved among New
World and Australian isolates of the parasite (45) and en-
codes a 77-kDa merozoite protein that is inducible by
oxidative or nutritional stress (34a), does not elicit prolifer-
ation of this clone. The identity of the protein that stimulates
clone C97.3C3 is not known.
Clones representative of the other three groups (C15.1H6,
C97.3E9, and C15.2D7 and C15.3A5) were stimulated by
fractions eluting between 0.35 and 0.45 M NaCl that con-
tained prominent bands of 42, 47, 56, and 84 kDa. Since none
of the Th clones recognized recombinant Bv42, the 42-kDa
protein is not a likely candidate immunogen for these clones,
although in its native and recombinant states, this protein is
very immunogenic, stimulating both strong humoral and T
cell responses in immune cattle (11, 13, 24). Combined
protein fractionation protocols, including FPLC anion ex-
change, gel filtration, and isoelectric focusing, will be used to
purify and identify the immunodominant T cell epitopes
present in soluble fractions of B. bovis merozoites. How-
ever, as noted by us (12) and others (49), protozoal antigens
which stimulate T cells may not be abundant and therefore
may prove difficult to identify by biochemical purification.
Because the nature of the immune response and the
induction of immune-mediated pathology elicited by immu-
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nization with a defined babesial protein will reflect the
cytokines produced by antigen-activated T cells and macro-
phages, we have measured cytokines produced by the Babe-
sia-specific Th clones. Biological assays revealed a differen-
tial production of IFN-y and TNF-a/TNF-1, suggesting
functional differences among the Th clones. All clones in
groups I to IV produced IFN--y, and some clones in each
group produced TNF, whereas none of the clones in group V
produced either cytokine. All of the clones in groups I to IV
also produced TCGF activity (data not presented), but
bioassays that distinguish bovine IL-2 and IL-4 activities are
currently not available. For this reason, analysis of the
expression by these cells of mRNA encoding IFN--y, IL-2,
IL-4, TNF-1, and TNF-ct is being performed to determine
whether these B. bovis-specific Th clones can be classified as
either Thl or Th2 cells (30).
As T cell immunogenic antigens of B. bovis become
identified and available in purified or recombinant form, it
will possible to define, at the molecular level, the complex
interactions among bovine T cells, macrophages, and para-
site antigens important in designing vaccines that will induce
protective antiparasite immunity or limit immune-mediated
pathology. Our aim is to select, for vaccine trials, antigens
that induce an inflammatory or Thl type of response which
in other protozoal infections is associated with protective
immunity.
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